Press Releases
Trophos announces positive interim review in pivotal study of...
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for under-served medical needs in neurology and cardiology, announces...
Press Releases
Okairos Initiates Phase I Clinical Trial Evaluating Vaccine against...
Okairos today announced the initiation of a Phase I clinical trial evaluating a vaccine against respiratory syncytial virus (RSV), a leading cause of hospital...
Press Releases
Quinten identifies a combination of two synergistic markers that...
Quinten, a strategic and operational consulting company specializing in the evaluation of biomedical data in the pharmaceutical, biotechnology and cosmetic industries, today announces the...
Press Releases
Affymax and Takeda Announce a Nationwide Voluntary Recall of...
Affymax, Inc. and Takeda Pharmaceutical Company Limited (Takeda) today have decided to voluntarily recall all lots of OMONTYS® (peginesatide) Injection to the user level...
Press Releases
Shimojani Licenses New Stroke Therapy from Niigata University
Shimojani LLC, a privately held biotech company, today announced that it has acquired an exclusive license from Niigata University for worldwide development and commercialization...
Press Releases
Sprig Health Offers Uninsured Individuals up to 50 percent...
The Affordable Care Act has already made certain health care services more accessible and affordable, but today's uninsured individuals still cannot afford the high...
Press Releases
CiToxLAB Group increases revenue by 25 per cent over...
CiToxLAB, a leading CRO in the field of non-clinical research, announces today that the group’s consolidated revenue for 2012 reached EUR 78.4 million (USD...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.